Home » MolecularMD to Offer Promega Microsatellite Instability Technology

MolecularMD to Offer Promega Microsatellite Instability Technology

Nov 14, 2017
|
staff reporter

NEW YORK (GenomeWeb) – MolecularMD announced today that it will now provide Promega's Microsatellite Instability (MSI) v1.2 Analysis System as part of a larger portfolio of diagnostic and clinical research products aimed at supporting the development of oncology drugs and clinical trials.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Drive Away the Flies

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

Fewer Transfusions Needed

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Alteration Here and There to Win

Futurism writes that gene doping could be the next generation of cheating in sports.

This Week in Nature

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

What's Popular?

In Business News

  1. Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy

  2. AACR Business Roundup: Thermo Fisher, Mission Bio, Stand Up To Cancer, Cancer Research UK

  3. Danaher Q1 Revenues Grow 12 Percent

  4. DiaCarta, MIODx to Codevelop Diagnostic to Predict Immunotherapy Response

  5. Twist Bioscience Inks Asian Distribution Deals

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.